ImmunologybioRxivPreprint
Discovery of a novel monoclonal PD-L1 antibody H1A that promotes T-cell mediated tumor killing activity in renal cell carcinoma
Z. An, M. A. Hsu, J. K. Gicobi…·F. Lucien
This study identifies a novel monoclonal PD-L1 antibody H1A that enhances T-cell mediated tumor killing in renal cell carcinoma compared to existing PD-1/PD-L1 inhibitors.
DOI 10.1101/2022.09.10.507426